Health Care Archives - Page 35 of 478

1 minute read

Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars

April 24, 12:42 PM

Boston Scientific reports impressive Q1 earnings, with revenues of $3.86 billion, beating estimates. Cardiovascular segment leads with $2.4 billion sales, up 15.9%. Outlook: 2024 net sales growth forecasted at 11%-13%, adjusted EPS at $2.29-$2.34.

BSX

2 minute read

Biogen’s Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings

By Vandana Singh

April 24, 12:12 PM

Biogen reports Q1 results: adjusted EPS $3.67 (beat consensus), sales $2.29 billion (missed consensus). Leqembi launch uptake triples, Zurzuvae's early trends encouraging.

BIIB

2 minute read

Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?

By Vandana Singh

April 24, 10:43 AM

Immutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line treatment of HNSCC patients without PD-L1 expression. Final data expected in H1 CY2024.

IMMP

1 minute read

Thermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip

By Vandana Singh

April 24, 10:38 AM

Discover Thermo Fisher Scientific Inc's (NYSE: TMO) Q1 earnings: $10.34 billion revenue, down 3% Y/Y, with beats in EPS and guidance. Dive into details now.

TMO

1 minute read

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

By Vandana Singh

April 24, 10:31 AM

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about its broad impact on lung, colorectal, and pancreatic cancers, achieving significant milestones in collaboration and intellectual property.

GILD

1 minute read

Humana Boosts Medicare Advantage Membership 2024 Forecast As Q1 Earnings Performance Exceeds Expectations

By Vandana Singh

April 24, 10:10 AM

Humana reports Q1 adjusted EPS of $7.23, surpassing expectations. Revenues rise to $29.33 billion driven by Medicare premiums and Advantage membership growth. Guidance reaffirms confidence in future earnings.

HUM

2 minute read

Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast

By Vandana Singh

April 24, 10:00 AM

Evotec undergoes a strategic shift for sustainable growth in 2024. Priority reset to optimize operations; expect double-digit revenue growth & EBITDA improvement. New CEO appointed. Guidance and mid-term outlook update forthcoming in August 2024.

EVO

2 minute read

Patient Data Compromised – UnitedHealth Group Admits Ransom Payment in Cyberattack

By Vandana Singh

April 23, 3:09 PM

UnitedHealth Group disclosed ransom payments after the cyberattack on Change Healthcare. Breach exposes personal data, impacting millions. The company cooperates with law enforcement for a thorough investigation.

UNH

1 minute read

FDA Approves Novartis’ Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors

By Vandana Singh

April 23, 3:05 PM

Discover Novartis' FDA approval for Lutathera in pediatric patients with GEP-NETs, marking a pivotal milestone in treating this rare cancer. Explore its efficacy in combating SSTR+ tumors, backed by robust trial data.

NVS

2 minute read

Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends

By Vandana Singh

April 23, 3:03 PM

Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow.

INCY